Market Outlook
The North America Clot Management Devices Market was valued at USD 860.31 million in 2023 and is anticipated to project robust growth through 2029, driven by rising incidences of cardiovascular and neurovascular disorders. Increasing adoption of minimally invasive procedures and the growing geriatric population, which is more susceptible to thrombotic diseases, are significantly driving demand. Healthcare providers in North America are increasingly turning to clot management device